0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Artelo Biosciences Inc - Trending symbols

Latest News of Artelo Biosciences Inc

DateTitleRead
2025-08-01
13:56
Artelo Biosciences stock surges after receiving favorable UK regulatory guidanceRead
2025-08-01
13:45
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and DepressionRead
2025-07-11
22:52
Artelo Biosciences completes reverse stock split and reports preliminary Q2 financialsRead
2025-07-09
15:02
Artelo Biosciences stock soars after positive preclinical pain dataRead
2025-07-09
13:57
Artelo Biosciences presents positive data for arthritis pain drugRead
2025-07-09
13:50
Artelo Biosciences Announces Positive Preclinical Efficacy Data for ART26.12 in Osteoarthritis Pain at the 35th Annual International Cannabinoid Research Society SymposiumRead
2025-07-08
13:57
Artelo stock rating upgraded to Buy by D. Boral Capital on pipeline potentialRead



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Net Working Capital 7,467-2,2395,228-9394,289-3,504785-2,207-1,422
EBITDA -2,394-945-3,339-137-3,4761,507-1,9692,134165
Net Interest Income 1010101-6-5
Total Other Income Expense Net 202-1044-23-19
Accumulated Other Comprehensive Income 48048149-3118-41-23

Comments

How you think about this?

Leave a comment

Stay informed about Artelo Biosciences Inc.

Receive notifications about Artelo Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.